Publications by authors named "Emmanuel Blot"

Claim this Profile
A
Adjuvant chemotherapy and hormonotherapy versus adjuvant hormonotherapy alone for women aged 70 years and older with high-risk breast cancer based on the genomic grade index (ASTER 70s): a randomised phase 3 trial.
Etienne Brain, Olivier Mir, Emmanuelle Bourbouloux, Olivier Rigal, Jean-Marc Ferrero, Emmanuel Blot

Lancet· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adapted EXTREME regimen in the first-line treatment of fit, older patients with recurrent or metastatic head and neck squamous cell carcinoma (ELAN-FIT): a multicentre, single-arm, phase 2 trial.
Joël Guigay, Hervé Le Caer, François-Régis Ferrand, Lionel Geoffrois, Esma Saada-Bouzid, Emmanuel Blot

Lancet Healthy Longev· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trial.
Joël Guigay, Cécile Ortholan, Damien Vansteene, Didier Cupissol, Caroline Even, Emmanuel Blot

Lancet Healthy Longev· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Observational, prospective, phase 4 study in patients with first-line recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with cetuximab and platinum-based therapy: DIRECT.
Joël Guigay, Emmanuel Chamorey, Gautier Lefebvre, Maciej Rotarski, Jean-Philippe Wagner, Emmanuel Blot

Cancer Rep (Hoboken)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-pegylated liposomal doxorubicin (NPLD, Myocet®) + carboplatin in patients with platinum sensitive ovarian cancers: A ARCAGY-GINECO phase IB-II trial.
Clémence Romeo, Florence Joly, Isabelle Ray-Coquard, Claude El Kouri, Anne Mercier-Blas, Emmanuel Blot

Gynecol Oncol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study.
Jean Louis Lefebvre, Yoann Pointreau, Frederic Rolland, Marc Alfonsi, Alain Baudoux, Emmanuel Blot

J Clin Oncol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian cancer: Stat3, RhoA and IGF-IR as therapeutic targets.
Caroline Gest, Pezhman Mirshahi, Hong Li, Linda-Louise Pritchard, Ulrich Joimel, Emmanuel Blot

Cancer Lett· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated HER2 extracellular domain level in primary breast cancer with HER2 overexpression predicts early failure of adjuvant trastuzumab.
Sebastien Thureau, Florian Clatot, Sophie Laberge-Le-Couteulx, Marc Baron, Jean-Pierre Basuyau, Emmanuel Blot

Anticancer Res· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoural level of SDF-1 correlates with survival in head and neck squamous cell carcinoma.
Florian Clatot, Jean-Michel Picquenot, Olivier Choussy, Sophie Gouérant, Cristian Moldovan, Emmanuel Blot

Oral Oncol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of liposomal doxorubicin-based adjuvant chemotherapy on autonomy in women over 70 with hormone-receptor-negative breast carcinoma: A French Geriatric Oncology Group (GERICO) phase II multicentre trial.
Etienne G C Brain, Cécile Mertens, Véronique Girre, Frédérique Rousseau, Emmanuel Blot

Crit Rev Oncol Hematol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Improvement and Prolonged Survival With High Dose Intrathecal Methotrexate for Carcinomatous Meningitis Secondary to a Lung Adenocarcinoma.
Florian Clatot, Philippe David, Sophie Laberge-Le-Couteulx, Emmanuel Blot

World J Oncol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial.
Hervé Bonnefoi, Martine Piccart, Jan Bogaerts, Louis Mauriac, Pierre Fumoleau, Emmanuel Blot

Lancet Oncol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction--Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial.
Hervé Bonnefoi, Anil Potti, Mauro Delorenzi, Louis Mauriac, Mario Campone, Emmanuel Blot

Lancet Oncol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stimulation of angiogenesis resulting from cooperation between macrophages and MDA-MB-231 breast cancer cells: proposed molecular mechanism and effect of tetrathiomolybdate.
Ulrich Joimel, Caroline Gest, Jeannette Soria, Linda-Louise Pritchard, Jérôme Alexandre, Emmanuel Blot

BMC Cancer· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical improvement and survival in breast cancer leptomeningeal metastasis correlate with the cytologic response to intrathecal chemotherapy.
Florian Clatot, Géraldine Philippin-Lauridant, Matthieu-John Ouvrier, Tony Nakry, Sophie Laberge-Le-Couteulx, Emmanuel Blot

J Neurooncol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer.
Pierre Farmer, Hervé Bonnefoi, Pascale Anderle, David Cameron, Pratyaksha Wirapati, Emmanuel Blot

Nat Med· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CXCR4 membrane expression in node-negative breast cancer.
Emmanuel Blot, Sophie Laberge-Le Couteulx, Hossein Jamali, Marie Cornic, Cécile Guillemet

Breast J· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: findings from the EORTC 10001 randomized phase II trial.
Bojana Pajk, Tanja Cufer, Peter Canney, Paul Ellis, David Cameron, Emmanuel Blot

Breast· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial.
Hervé Bonnefoi, Anil Potti, Mauro Delorenzi, Louis Mauriac, Mario Campone, Emmanuel Blot

Lancet Oncol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outpatient oral antibiotics for febrile neutropenic cancer patients.
Matthieu-John Ouvrier, Jean-Christophe Thery, Emmanuel Blot

J Clin Oncol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delay of postoperative radiotherapy in head and neck cancer patients.
Emmanuel Blot, Emilie Astruc, Laurent Bastit

J Clin Oncol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dalteparin compared with an oral anticoagulant for thromboprophylaxis in patients with cancer.
Emmanuel Blot, Fabrice Gutman, Alexia Thannberger

N Engl J Med· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemoradiotherapy in unresectable squamous cell head and neck cancer.
Emmanuel Blot, Elsie Staub

J Clin Oncol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical efficacy of irradiation in CLL patients: predictive value of in vitro radio-induced apoptosis.
Didier Decaudin, Jozo Delic, Janine Dumont, Gérard Tertian, Emmanuel Blot

Leuk Lymphoma· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-related thrombotic microangiopathy secondary to Von Willebrand factor-cleaving protease deficiency.
Emmanuel Blot, Didier Decaudin, Agnès Veyradier, Armelle Bardier, Odette-Lyvia Zagame

Thromb Res· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis